Gratia Capital’s Chemours CC Stock Holding History

Gratia Capital’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-10,800	Closed	-$195K	–	17
2019 Q4	$195K	Hold	10,800	–	–	0.24%	26
2019 Q3	$161K	Buy	+10,800	New	+$176K	0.27%	22

Other funds holding CC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Gratia Capital's CC Position: Q1 2020 in Review

Gratia Capital sold out of Chemours (CC) in Q1 2020, closing a stake of 10,800 shares — an estimated $195K sold.

Gratia Capital first reported a position in CC in Q3 2019 and held it in 2 quarters. The position peaked at $195K in Q4 2019. 416 funds tracked by Wall St. Rank hold CC as of Q1 2020.

Gratia Capital reported no remaining Chemours position as of Q1 2020 after selling out during the quarter.
Gratia Capital sold 10,800 Chemours shares in Q1 2020, an estimated $195K.
Gratia Capital first reported a position in Chemours in Q3 2019 and held it in 2 quarters.
Gratia Capital's Chemours position peaked at $195K in Q4 2019.
416 funds tracked by Wall St. Rank held Chemours as of Q1 2020.

Based on Gratia Capital's 13F filing for Q1 2020, filed 15 May 2020.